Overview

Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects

Status:
Completed

Trial end date:
2021-03-18

Target enrollment:

Participant gender:

Summary

The objective of this study is to examine the effect of a single IV dose of ketamine (0.5 mg/kg) on laboratory-induced stress in healthy participants.

Phase:

Phase 2

Details

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Treatments:

Ketamine
Midazolam